Marrone Bio Innovations Begins Production At Bangor, Michigan, Facility
The company said “revitalization and expansion of the facility will be completed in multiple phases with an anticipated total capital expenditure of $32 million. Installation of the first of three fermentation tanks, and the construction of a dedicated building to house them, marks the completion of phase 1A of the project.”
“Future phases will include production of the company's Regalia biofungicide, as well as increasing the capacity of the utilities and installing larger fermenters that will accommodate production of multiple products at higher volumes,” the company said.
"Producing this first batch of Grandevo is an important milestone in meeting the margin objectives we have set for 2014," explains Hector Absi, Senior V ice President of Commercial Operations for MBI. "As we expect to continue delivering double digit sales growth of our existing products and plan for new product introductions, this new manufacturing capability will allow faster scale up, make us much more responsive to surges in market demand and more effective in managing our production costs."
"This is a key accomplishment for our company, but there is more to be done to fulfill our manufacturing plan. Our priority is to ensure we have the capability, and flexibility, to meet the exciting sales targets we have set for 2014," Absi added.
Dollar General Plans Walton, Kentucky Distribution Center and Bowling Green Cold Storage Hub
2019 Leading Metro Locations: Pacific and South-Atlantic Metros Dominate the List
2019 Top States for Doing Business: Georgia Ranks #1 Sixth Year in a Row
Site Selection 2020: The Importance of “Regional Depth” with Global Reach
A Heightened Focus on Reshoring
How are Uncertain Times Altering Company Location Strategies?
34th Annual Corporate Survey & the 16th Annual Consultants Survey